Tag Archives: Data

Practices need to vastly improve data accuracy in records, attorney says

The processes of medical recordkeeping continue to change, as regulators more frequently set new requirements, and many healthcare organizations struggle to keep up with the changes. But the big problem is that too many hospitals and practices still haven’t managed the basics of collecting and reporting data for regulators and attorneys, Isabelle Bebit-Kilinyak, a corporate… Read More »

Data from homeless emergency department patients finds multiple contributors to homelessness

A qualitative study of recently homeless emergency department patients found multiple contributors to homelessness that can inform future homelessness prevention interventions. The study findings are published in the September issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine. Homelessness is a social determinant of health, and ranks alongside age, transportation… Read More »

How to get the data right to advance collaboration, build trust

In the decade has since the Affordable Care Act was enacted, adoption of electronic health records has broadened significantly, and technology has exponentially increased the amount of information healthcare professionals have about their patients. Through mandating transparency of medical records, the reality of interoperability—the ability to efficiently and effectively share patient information with patients and… Read More »

Veradigm, Komodo Health work on new data set for life sciences

Veradigm, a payer and life sciences unit within Allscripts, has partnered with Komodo Health to create the largest linked electronic medical records and claims data set for life science research. The program combines Veradigm’s EHR data from Allscripts with a healthcare map from Komodo that offers almost 50 million linked and longitudinal patient records. The… Read More »

FDA says some data testing Novartis’ $2 million gene therapy was manipulated

NEW YORK (Reuters) – The U.S. Food and Drug Administration said on Tuesday that some data from early testing of Novartis’ more than $ 2 million gene therapy Zolgensma was manipulated, but the agency believes the treatment should remain on the market. FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is… Read More »